UMB Data Catalog
A project of the Health Sciences and Human Services Library60 Years after Kefauver: Household income required to buy prescription drugs in the United States and abroad
UMB Dataset
UID: 199
- Description
- Using the framework of the historical analysis presented to the Senate Subcommittee on Antitrust and Monopoly, drug prices relative to income in the United States are compared to other Organization for Economic Co-Operation and Development (OECD) countries to improve treatment access and affordability. Countries were selected based on drug price and income data availability and inclusion in the OECD. 40 drugs, 20 brand name and 20 generic, were selected based on revenue sales and prescription volume in 2018. Domestic pricing data included list price, measured by Average Wholesale Price (AWP), and retail price available on GoodRx.com. International drug price data was sourced from publicly available databases on individual country websites. The first analysis illustrates the percentage of household disposable income needed to cover a year supply of a select product. The second analysis illustrates country-specific difference in drug affordability. The last analysis examines the percent of resources an average family, about three persons, would spend on medication in the United Sates if they were a member of different income groups.
- Timeframe
- 2018
- Geographic Coverage
-
AustraliaCanadaCzech RepublicDenmarkFranceSee all...NetherlandsNew ZealandNorwayPortugalSwedenUnited States
-
Access via Article
Datatables
Access via Supplementary materialDatatables
- Access Restrictions
-
Unrestricted access
- Access Instructions
- Access data via article and supplementary materials
- Associated Publications
- Data Type
- Study Type
-
Observational
- Dataset Format(s)
- DOCX
- Data Collection Instruments
-
Micromedex
- Dataset Size
- 4.6 mb
Do you have or know of a dataset that should be added to the catalog? Let us know!